| View | NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys) | Pathogenic | von Willebrand disease type 2B | 2024-08-19 | 1.3 | ClinGen von Willebrand Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for VWF Version 1.0.0 | VWF |
| View | NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys) | Pathogenic | von Willebrand disease type 2B | 2024-08-12 | 1.2 | ClinGen von Willebrand Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for VWF Version 1.0.0 | VWF |
| View | NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys) | Pathogenic | von Willebrand disease type 2B | 2024-08-12 | 1.1 | ClinGen von Willebrand Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for VWF Version 1.0.0 | VWF |
| View | NM_000552.4(VWF):c.3922C>T (p.Arg1308Cys) | Pathogenic | von Willebrand disease type 2B | 2024-08-09 | 1.0 | ClinGen von Willebrand Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for VWF Version 1.0.0 | VWF |